Tremor
TrialsCompanies

Not investment advice.

Tremor shows what changed in public records. It never tells anyone to buy or sell. Many trial edits are harmless paperwork. Data from ClinicalTrials.gov, the SEC, and the Federal Register.

PrivacyTerms

HCMHutchmedSigning up patients

HMPL-453 Tartrate in Advanced Intrahepatic Cholangiocarcinoma

Advanced Intrahepatic Cholangiocarcinoma · Solid Tumor, Adult

0Calmworry score, out of 100

No strong warning signs right now. The score counts warning signs; it is not a prediction.

Why this score

No warning signs right now. That's why the score is 0.

Score over time

Stage
Phase 2/3
Patients
235 (planned)
Started
Sep 3, 2020
Main results expected
Jun 30, 2028
Fully finished
Feb 28, 2030
Results posted
not yet

What counts as success

The trial's main goal(s), called the “primary outcome.”

  • Overall response rate (ORR)

    Measured over: Measured up to 6 months after the last patient has been enrolled or all patients have finished their last PFS follow up, whichever comes first

Changes Tremor has spotted

No changes since Tremor started watching this trial.
Show details (technical version)

Score inputs

  • none

Raw record changes

  • none yet

Trial ID NCT04353375 · record last updated 2025-12-31 · checked 2026-11-09 15:36 UTC

See the official record on ClinicalTrials.gov (NCT04353375) ↗